Depression—A Major Contributor to Poor Quality of Life in Patients With Advanced Cancer

Journal of Pain and Symptom Management

Volumn 54, Issue 6, 2017, Pages 889-897

  Grotmol, Kjersti S ^a   Lie, Hanne C ^a,b   Hjermstad, Marianne J ^a,c   Aass, Nina ^a,b   Currow, David ^d   Kaasa, Stein ^a,b,c   Moum, Torbjørn Å ^b   Pigni, Alessandra ^e   Loge, Jon Håvard ^a,c  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^d FLINDERS UNIVERSITY   (Australia)

^e NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

advanced cancer; Depression; population study; prognosis; quality of life

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; ADVANCED CANCER; ARTICLE; BREAST CANCER; BRIEF PAIN INVENTORY; CANCER CHEMOTHERAPY; CANCER PATIENT; COMORBIDITY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEPRESSION; DIGESTIVE SYSTEM CANCER; DISEASE SEVERITY; DYSPNEA; EDMONTON SYMPTOM ASSESSMENT SCALE; FEMALE; GLASGOW PROGNOSTIC SCORE; HUMAN; KARNOFSKY PERFORMANCE STATUS; LOSS OF APPETITE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NAUSEA; PAIN; PAIN INTENSITY; PATIENT HEALTH QUESTIONNAIRE 9; PHYSICAL PERFORMANCE; PROGNOSTIC ASSESSMENT; QUALITY OF LIFE; QUALITY OF LIFE ASSESSMENT; SYMPTOM ASSESSMENT; ADOLESCENT; AGED; CLINICAL TRIAL; COST OF ILLNESS; MULTICENTER STUDY; NEOPLASM; PROGNOSIS; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGY; SEVERITY OF ILLNESS INDEX; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; COMORBIDITY; COST OF ILLNESS; CROSS-SECTIONAL STUDIES; DEPRESSION; FEMALE; HUMANS; KARNOFSKY PERFORMANCE STATUS; MALE; MIDDLE AGED; NEOPLASMS; PAIN; PROGNOSIS; PSYCHIATRIC STATUS RATING SCALES; QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 85035778436     PISSN: 08853924     EISSN: 18736513     Source Type: Journal    
DOI: 10.1016/j.jpainsymman.2017.04.010     Document Type: Article

References (41)

1. WHO. WHO definition of palliative care 2002. Available from http://www.who.int/cancer/palliative/definition/en. Accessed October 2016.
2. Guidance for industry. Patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance. Health Qual Life Outcomes, 4, 2006, 79.
3. Smith, T.J., Temin, S., Alesi, E.R., et al. American Society of Clinical Oncology provisional clinical opinion: the integration of palliative care into standard oncology care. J Clin Oncol 30 (2012), 880–887.
4. Temel, J.S., Greer, J.A., Muzikansky, A., et al. Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med 363 (2010), 733–742.
5. Westhoff, P.G., De Graeff, A., Monninkhof, E.M., et al. Quality of life in relation to pain response to radiation therapy for painful bone metastases. Int J Radiat Oncol Biol Phys 93 (2015), 694–701.
6. Maltoni, M., Prognostic factors in advanced cancer patients: evidence-based clinical recommendations-a study by the Steering Committee of the European Association for Palliative Care. J Clin Oncol 23 (2005), 6240–6248.
7. Zimmermann, C., Burman, D., Swami, N., et al. Determinants of quality of life in patients with advanced cancer. Support Care Cancer 19 (2011), 621–629.
8. Jordhøy, M.S., Quality of life in advanced cancer patients: the impact of sociodemographic and medical characteristics. Br J Cancer 85 (2001), 1478–1485.
9. Laird, B.J., Fallon, M., Hjermstad, M.J., et al. Quality of life in patients with advanced cancer: differential association with performance status and systemic inflammatory response. J Clin Oncol 34 (2016), 2769–2775.
10. Smith, E.M., Gomm, S.A., Dickens, C.M., Assessing the independent contribution to quality of life from anxiety and depression in patients with advanced cancer. J Palliat Med 17 (2003), 509–513.
11. Garvin, P., Nilsson, E., Ernerudh, J., Kristenson, M., The joint subclinical elevation of CRP and IL-6 is associated with lower health-related quality of life in comparison with no elevation or elevation of only one of the biomarkers. Qual Life Res 25 (2016), 213–221.
12. Mitchell, A.J., Chan, M., Bhatti, H., et al. Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: a meta-analysis of 94 interview-based studies. Lancet Oncol 12 (2011), 160–174.
13. Lie, H.C., Hjermstad, M.J., Fayers, P., Finset, A., Kaasa, S., Loge, J.H., Depression in advanced cancer – assessment challenges and associations with disease load. J Affect Disord 173 (2015), 176–184.
14. Brown, L.F., Kroenke, K., Theobald, D.E., Wu, J., Tu, W., The association of depression and anxiety with health-related quality of life in cancer patients with depression and/or pain. Psychooncology 19 (2010), 7314–7341.
15. Lloyd Williams, M., Shiels, C., Taylor, F., Dennis, M., Depression — an independent predictor of early death in patients with advanced cancer. J Affect Disord 113 (2009), 127–132.
16. Fainsinger, R.L., Nekolaichuk, C.L., Lawlor, P.G., Neumann, C.M., Hanson, J., Vigano, A., A multicenter study of the revised Edmonton Staging System for classifying cancer pain in advanced cancer patients. J Pain Symptom Manage 29 (2005), 224–237.
17. Rayner, L., Lee, W., Price, A., et al. The clinical epidemiology of depression in palliative care and the predictive value of somatic symptoms: cross-sectional survey with four-week follow-up. J Palliat Med 25 (2011), 229–241.
18. Daly, E.J., Trivedi, M.H., Wisniewski, S.R., et al. Health-related quality of life in depression: a STAR*D report. Ann Clin Psychiatry 22 (2010), 43–55.
19. Vodermaier, A., Millman, R.D., Accuracy of the Hospital Anxiety and Depression Scale as a screening tool in cancer patients: a systematic review and meta-analysis. Support Care Cancer 19 (2011), 1899–1908.
20. Wong, E., Chow, E., Zhang, L., et al. Factors influencing health related quality of life in cancer patients with bone metastases. J Palliat Med 16 (2013), 915–921.
21. Hjermstad, M., Lie, H., Caraceni, A., et al. Computer-based symptom assessment is feasible in patients with advanced cancer: results from an international multicenter study, the EPCRC-CSA. J Pain Symptom Manage 44 (2012), 639–654.
22. Folstein, M.F., Folstein, S.E., McHugh, P.R., “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12 (1975), 189–198.
23. Brændengen, M., Tveit, K., Hjermstad, M., et al. Health-related quality of life (HRQoL) after multimodal treatment for primarily non-resectable rectal cancer. Long-term results from a phase III study. Eur J Cancer 48 (2012), 813–819.
24. Fayers, P.A.N., Bjordal, K., Curran, D., Groenvold, M., on behalf of the EORTC Quality of Life Study Group. EORTC QLQ-C30 Scoring Manual. 3rd ed, 2001, EORTC, Brussels, Belgium.
25. Smith, A.B., Cocks, K., Taylor, M., Parry, D., Most domains of the European organisation for research and treatment of cancer quality of life questionnaire C30 are reliable. J Clin Epidemiol 67 (2014), 952–957.
26. Karnofsky, D., The use of nitrogen mustards in the palliative treatment of carcinoma with particular reference to bronchogenic carcinoma. Cancer 1 (1948), 634–656.
27. Phillips, R., Gandhi, M., Cheung, Y.B., et al. Summary scores captured changes in subjects' QoL as measured by the multiple scales of the EORTC QLQ-C30. J Clin Epidemiol 68 (2015), 895–902.
28. Forrest, L.M., McMillan, D.C., McArdle, C.S., Angerson, W.J., Dunlop, D.J., Evaluation of cumulative prognostic scores based on the systemic inflammatory response in patients with inoperable non-small-cell lung cancer. Br J Cancer 89 (2003), 1028–1030.
29. Bruera, E., The Edmonton Symptom Assessment System (ESAS): a simple method for the assessment of palliative care patients. J Palliat Care 7 (1991), 6–9.
30. Daut, R.L., Cleeland, C.S., Flanery, R.C., Development of the Wisconsin Brief Pain Questionnaire to assess pain in cancer and other diseases. Pain 17 (1983), 197–210.
31. Johns, S.A., Kroenke, K., Krebs, E.E., Theobald, D.E., Wu, J., Tu, W., Longitudinal comparison of three depression measures in adult cancer patients. J Pain Symptom Manage 45 (2013), 71–82.
32. Spitzer, R.L., Kroenke, K., Williams, J.B., Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary care evaluation of mental disorders. Patient health questionnaire. JAMA 282 (1999), 1737–1744.
33. Kroenke, K., Spitzer, R., Williams, J.B.W., The PHQ-9. J Gen Intern Med 16 (2001), 606–613.
34. Barrera, I., Spiegel, D., Review of psychotherapeutic interventions on depression in cancer patients and their impact on disease progression. Int Rev Psychiatry 26 (2014), 31–43.
35. Brelin, S., Loge, J., Skurtveit, S., et al. Antidepressants to cancer patients during the last year of life-a population-based study. Psychooncology 22 (2013), 506–514.
36. Janda, M., DiSipio, T., Hurst, C., Cella, D., Newman, B., The Queensland cancer risk study: general population norms for the functional assessment of cancer therapy-general (FACT-G). Psychooncology 18 (2009), 606–614.
37. Lundh Hagelin, C.L., Lundh Hagelin, C., Seiger, Å., Fürst, C.J., Quality of life in terminal care—with special reference to age, gender and marital status. Support Care Cancer 14 (2006), 320–328.
38. Johansson, R., Carlbring, P., Heedman, A., Paxling, B., Andersson, G., Depression, anxiety and their comorbidity in the Swedish general population: point prevalence and the effect on health-related quality of life. Peer J, 1, 2013, e98.
39. Hjermstad, M.J., Fayers, P.M., Bjordal, K., Kaasa, S., Health-related quality of life in the general Norwegian population assessed by the European Organization for Research and Treatment of Cancer Core Quality-of-Life Questionnaire: the QLQ=C30 (+ 3). J Clin Oncol 16 (1998), 1188–1196.
40. Andersen, B.L., DeRubeis, R.J., Berman, B.S., et al. Screening, assessment, and care of anxiety and depressive symptoms in adults with cancer: an American Society of Clinical Oncology guideline adaptation. J Clin Oncol 32 (2014), 1605–1619.
41. Gilbertson-White, S., Aouizerat, B.E., Jahan, T., Miaskowski, C., A review of the literature on multiple symptoms, their predictors, and associated outcomes in patients with advanced cancer. Palliat Support Care 9 (2011), 81–102.